adn 138 has been researched along with ciglitazone in 1 studies
| Studies (adn 138) | Trials (adn 138) | Recent Studies (post-2010) (adn 138) | Studies (ciglitazone) | Trials (ciglitazone) | Recent Studies (post-2010) (ciglitazone) |
|---|---|---|---|---|---|
| 5 | 0 | 0 | 473 | 0 | 77 |
| Protein | Taxonomy | adn 138 (IC50) | ciglitazone (IC50) |
|---|---|---|---|
| Epidermal growth factor receptor | Homo sapiens (human) | 4.655 | |
| Carbonic anhydrase 2 | Homo sapiens (human) | 0.086 | |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 2.22 | |
| Adenosine receptor A3 | Homo sapiens (human) | 3.047 | |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Homo sapiens (human) | 2.7 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 3.047 | |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 2.22 | |
| Amine oxidase [flavin-containing] B | Homo sapiens (human) | 0.225 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 3.047 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dietrich, A; Harrison, MC; Hohman, TC; McCaleb, M; Millen, J; Sredy, J; Sullivan, D; Woolson, SA; Wrobel, J | 1 |
1 other study(ies) available for adn 138 and ciglitazone
| Article | Year |
|---|---|
Novel spirosuccinimides with incorporated isoindolone and benzisothiazole 1,1-dioxide moieties as aldose reductase inhibitors and antihyperglycemic agents.
Topics: Aldehyde Reductase; Animals; Blood Glucose; Cattle; Diabetes Mellitus, Experimental; Glyceraldehyde; Hypoglycemic Agents; Indoles; Male; Mice; Mice, Inbred C57BL; Molecular Structure; Rats; Structure-Activity Relationship; Succinimides; Thiazoles; Thiazolidinediones | 1992 |